CoreValve Successfully Initiates First North American Clinical Trial
December 14, 2005 Categories: Uncategorized Posted by adminCoreValve Uses its Novel ReValving(TM) System at Montreal Heart Institute to Non-Surgically Replace Diseased Aortic Heart Valve of 64-Year-Old Female Patient Not Eligible for Open-Heart Surgery.
Graphic by Ed. Wiederer
